Results
|
21.
|
|
|
22.
|
|
|
23.
|
|
|
24.
|
|
|
25.
|
|
|
26.
|
|
|
27.
|
|
|
28.
|
|
|
29.
|
|
|
30.
|
|
|
31.
|
|
|
32.
|
Elucidating the role of muscarinic receptors in psychosis. [electronic resource] by
- Felder, C C
- Porter, A C
- Skillman, T L
- Zhang, L
- Bymaster, F P
- Nathanson, N M
- Hamilton, S E
- Gomeza, J
- Wess, J
- McKinzie, D L
Producer: 20010621
In:
Life sciences vol. 68
Availability: No items available.
|
|
33.
|
Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. [electronic resource] by
- Yamada, M
- Lamping, K G
- Duttaroy, A
- Zhang, W
- Cui, Y
- Bymaster, F P
- McKinzie, D L
- Felder, C C
- Deng, C X
- Faraci, F M
- Wess, J
Producer: 20020108
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 98
Availability: No items available.
|
|
34.
|
Allosteric modulation of the muscarinic M4 receptor as an approach to treating schizophrenia. [electronic resource] by
- Chan, W Y
- McKinzie, D L
- Bose, S
- Mitchell, S N
- Witkin, J M
- Thompson, R C
- Christopoulos, A
- Lazareno, S
- Birdsall, N J M
- Bymaster, F P
- Felder, C C
Producer: 20080925
In:
Proceedings of the National Academy of Sciences of the United States of America vol. 105
Availability: No items available.
|
|
35.
|
Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effects. [electronic resource] by
- Witkin, J M
- Monn, J A
- Li, J
- Johnson, B
- McKinzie, D L
- Wang, X-S
- Heinz, B A
- Li, R
- Ornstein, P L
- Smith, S C
- Mitch, C H
- Calligaro, D O
- Swanson, S
- Allen, D
- Phillips, K
- Gilmour, G
Producer: 20171109
In:
Pharmacology, biochemistry, and behavior vol. 155
Availability: No items available.
|